Overall, GCMNs expressing Tf offer a promising approach for targeted therapy in cancer treatment.[99] Although Tf@IR820–DHA has successfully been used to target primary and distant tumor models in mice, further studies in primary carcinoma and large animal models are needed. The gene discussed is TF; the disease is carcinoma.